Tag

Nke

All articles tagged with #nke

Nike's Dividend Power Amid Buybacks Spurs Upside Despite Slump
investing21 days ago

Nike's Dividend Power Amid Buybacks Spurs Upside Despite Slump

Nike remains a strong dividend-growth story even as its stock is down roughly 33% year-to-date. The company has an $18 billion buyback and 24 years of consecutive dividend growth, bolstered by insider purchases (CEO Elliott Hill bought shares around $41–$42). Earnings have beaten estimates for four straight quarters, with Q3 FY26 EPS of $0.35 vs $0.28 expected, supported by solid North America momentum in Running and Global Football. Greater China revenue fell and tariffs pressured margins, yet Nike trades near $41.82 with a $58.72 analyst target and a majority of Buy ratings. The author argues the combination of a rising dividend, buyback-driven capital return, and insider confidence justifies continued dips-buying on a global athletic-utility thesis.

Nike Stock Plummets Amid Market Share Loss and Slowing Sales
finance2 years ago

Nike Stock Plummets Amid Market Share Loss and Slowing Sales

Nike (NKE) stock plummeted 8.7% after reporting Q3'2024 results and providing lackluster full-year guidance, with expected revenue growth of only 1%. Despite surpassing analysts' EPS expectations, the company's underwhelming outlook, particularly in Greater China and EMEA, contributed to the stock's decline. While the market views the news as significant, it doesn't fundamentally alter perceptions of the business. Nike's shares are down 11.3% since the start of the year, trading 26.1% below its 52-week high, presenting a potential buying opportunity for investors.

"Tesla and Activision Blizzard Among Today's Top Trending Stocks"
stock-market2 years ago

"Tesla and Activision Blizzard Among Today's Top Trending Stocks"

U.S. stocks traded higher, with the Dow Jones gaining over 110 points. Nike reported a 2% increase in revenue but a decline in North American sales. Carnival Corporation surged ahead of its third-quarter earnings report. Activision Blizzard faced regulatory hurdles but remained a significant player in the gaming industry. Madrigal Pharmaceuticals announced a $500 million public offering to fund clinical and commercial activities. Tesla's shares traded higher amid ongoing strikes at its competitors and positive analyst ratings.